IL6 and congenital rubella syndrome: Due to the fact that CRS is a severe and potentially deadly side effect, the application of Dabra should only be combined with CAR-T-cell therapy together with Tram, because this mitigates the IL-6 secretion and thus also the possible side effects of CRS.